...
首页> 外文期刊>European review for medical and pharmacological sciences. >Effects of tumor-specific antigen induced by lentinan on murine H22 hepatocellular carcinoma immunoprophylaxis
【24h】

Effects of tumor-specific antigen induced by lentinan on murine H22 hepatocellular carcinoma immunoprophylaxis

机译:香豆素诱导的肿瘤特异性抗原对小鼠H22肝癌免疫预防的影响。

获取原文
           

摘要

OBJECTIVE: Hepatocellular carcinoma (HCC) is one of the most prevalent tumor types and the third most common form of morbidity in cancer-related deaths worldwide. Lentinan isolated from Lentinus edodes, is known to be a biologically active macromolecule with extremely strong activation of the human immune system such as host-mediated anti-cancer activity. The aim of this study is to investigate the immunoprophylaxis effect of the antigens induced by lentinan on murine hepatocellular carcinoma. MATERIALS AND METHODS: The antigens were prepared by a co-culture method (HCL) and purified by ammonium sulfate fractionation precipitation (Z1, Z2, Z3). The effects of antigens on murine hepatocellular carcinoma immunoprophylaxis were determined in vivo. The cellular immunity of the immunized mice was tested by spleen lymphocyte proliferation tests and peritoneal macrophage phagocytosis assays. The tumor-specific antigen was confirmed by Western blot analysis. RESULTS: Results in vivo revealed that the antigens (HCL/Z1) activated immunoprophylaxis against hepatocellular carcinoma with a better survival status. The survival rates (60%, 100%) of the HCL/Z1 group were better than the model group (p < 0.01). The quantity of lymphocytes in the spleen in the HCL or Z1 groups treated with ConA or LPS were higher than that of the model group (p < 0.01). The phagocytosis ability of macrophages in the HCL or Z1 groups was better than that of the control group or model group (p < 0.01). The characterization of Western blot analysis showed that about 59.6kDa tumor specific antigen combined with antiserum of immunized mice specifically appeared in antigens. CONCLUSIONS: The newly generated tumor-specific antigen played a key role in the anti-tumor immune response and in activating the immune system. Our results suggest that this protein could serve as a tumor vaccine, and it could generate new ideas for tumor immunoprophylaxis.
机译:目的:肝细胞癌(HCC)是全世界癌症相关死亡中最普遍的肿瘤类型之一,也是第三大最常见的发病形式。分离自香菇的慢病毒,是一种具有生物活性的大分子,具有极强的人类免疫系统激活能力,例如宿主介导的抗癌活性。这项研究的目的是研究由香菇多糖诱导的抗原对小鼠肝细胞癌的免疫预防作用。材料与方法:通过共培养方法(HCL)制备抗原,并通过硫酸铵分级沉淀(Z1,Z2,Z3)纯化。在体内确定了抗原对鼠肝细胞癌免疫预防的作用。通过脾淋巴细胞增殖测试和腹膜巨噬细胞吞噬作用测试来测试免疫小鼠的细胞免疫性。通过蛋白质印迹分析确认了肿瘤特异性抗原。结果:体内结果表明,抗原(HCL / Z1)激活了对肝细胞癌的免疫预防,具有更好的生存状态。 HCL / Z1组的生存率(60%,100%)优于模型组(p <0.01)。用ConA或LPS治疗的HCL或Z1组脾脏淋巴细胞数量高于模型组(p <0.01)。 HCL或Z1组的巨噬细胞吞噬能力优于对照组或模型组(p <0.01)。 Western印迹分析的特征表明,约59.6kDa的肿瘤特异性抗原与免疫小鼠的抗血清结合特异性地出现在抗原中。结论:新产生的肿瘤特异性抗原在抗肿瘤免疫应答和激活免疫系统中起关键作用。我们的结果表明,这种蛋白质可以用作肿瘤疫苗,并且可以为肿瘤的免疫预防产生新的思路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号